designer491
Here’s a list of key deals reported across sectors this week:
- BioMarin Pharmaceutical (BMRN) has agreed to acquire rare disease drug developer Amicus Therapeutics (FOLD) in an all-cash transaction worth nearly $4.8B.
- Trump Media & Technology Group (DJT) and
